|
Volumn 141, Issue 37, 1999, Pages 38-40
|
Treatment of androgenetic alopecia with finasteride;Therapie der androgenetischen alopezie mit finasterid: Was sie bei beratung verordnung beachten mussen
|
Author keywords
5 reductase inhibitor; Androgenetic alopecia in the male; Dihydrotestosterone; Finasteride
|
Indexed keywords
ANDROSTANOLONE;
FINASTERIDE;
STEROID 5ALPHA REDUCTASE INHIBITOR;
TESTOSTERONE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
EJACULATION;
ERECTILE DYSFUNCTION;
HAIR GROWTH;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MALE SEXUAL DYSFUNCTION;
MALE TYPE ALOPECIA;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
TESTOSTERONE BLOOD LEVEL;
TESTOSTERONE METABOLISM;
ALOPECIA;
ENZYME INHIBITORS;
FINASTERIDE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0033575977
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (9)
|